Atlas Trials

Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan

Clinical trial NCT00840463 · TERMINATED

Trial details

NCT number
NCT00840463
Sponsor
University of Texas Southwestern Medical Center
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Pulmonary HypertensionHeart Failure With Preserved Ejection Fraction
Start date
2009-01-01
Primary completion
2013-09-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.